| 摘要 |
<p>The present application is directed to novel P2X7R antagonists that are N-indol-3-yl- acetamide and N-azaindol-3-yl-acetamide compounds, pharmaceutical compositions comprising the same and their use for the prophylactic or therapeutic treatment of diseases mediated by P2X7R activity.</p> |
